[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349556-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-349556-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","pan-cancer-profiles-of-mesothelin-msln-unveil-diagnostic-potential-and-therapeutic-targetability-of-pancreatic-adenocarcinoma-research-article","Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma - Research article","","Mesothelin (MSLN), a cell-surface glycoprotein implicated in multiple human malignancies, is evaluated for expression patterns, clinical implications, and drug-targeting potential across cancer types. Using transcriptomic and clinical datasets from TCGA and GEO, the study assesses diagnostic performance, prognostic value, and genomic alterations. Functional pathway enrichment and immune microenvironment signaling are analyzed. Drug sensitivity correlations and structure-based docking identify Withaferin A as a potent MSLN binder, supporting further optimization and experimental validation.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-profiles-of-mesothelin-msln-unveil-diagnostic-potential-and-therapeutic-targetability-of-pancreatic-adenocarcinoma-research-article/349556/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-profiles-of-mesothelin-msln-unveil-diagnostic-potential-and-therapeutic-targetability-of-pancreatic-adenocarcinoma-research-article/349556.png","ImageObject",300,407,{"name":42,"@type":43},"OmBimo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":30},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is the main goal of this study on mesothelin (MSLN)?","Question",{"text":62,"@type":63},"To systematically characterize MSLN expression patterns, its prognostic value, and its functional/therapeutic targeting potential across cancers, with emphasis on pancreatic adenocarcinoma.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How were MSLN expression and diagnostic/prognostic effects evaluated?",{"text":67,"@type":63},"The study used transcriptomic and clinical datasets from TCGA and GEO to assess MSLN expression, diagnostic value (ROC analysis), and prognostic significance (survival and Cox regression).",{"name":69,"@type":60,"acceptedAnswer":70},"Which computational approaches were used to explore therapeutic targeting?",{"text":71,"@type":63},"Genomic alterations and pathways were analyzed using mutation and functional enrichment (GO/KEGG). Drug sensitivity associations were tested with GDSC/CTRP, and structure-based screening used molecular docking plus 100 ns molecular dynamics and binding energy analysis, followed by ADMET-related assessments.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},349556,1790883157,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":30,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","OPEN ACCESS  \nCitation: Sheikh MR, Mistry B, Shafin RH, Apu A, Sara TH, Tasnim J, et al. (2026) Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma. PLoS One 21(8):  \ne0354334. [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0354334  \nEditor: Yusuf Oloruntoyin Ayipo, Kwara State University, NIGERIA  \nReceived: March 14, 2026  \nAccepted: July 4, 2026  \nPublished: August 20, 2026  \nCopyright: © 2026 Sheikh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are publicly available. RNA sequencing and clinical data for pancreatic adenocarcinoma (PAAD), cholangiocarcinoma (CHOL), stomach adenocarcinoma (STAD), lung adenocarcinoma (LUAD), ovarian serous cystadenocarcinoma  \nRESEARCH ARTICLE  \nPan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma  \nMd Ramjan Sheikh1*, Baishakhi Mistry2, Ridika Haque Shafin3, Amreeta Apu4, Tasnia Hossain Sara5, Jarin Tasnim6, Dipankar Dutta7, Aishwarya Nandy8, Anisur Rahman9  \n1 Department of Biochemistry and Molecular Biology, Hajee Mohammad Danesh Science and Technology University, Dinajpur, Bangladesh, 2 Department of Biotechnology and Genetic Engineering, Khulna University, Khulna, Bangladesh, 3 Department of Botany, University of Dhaka, Dhaka, Bangladesh, 4 Department of Genetic Engineering and Biotechnology, Jagannath University, Dhaka, Bangladesh, 5 Department of Biochemistry and Molecular Biology, Habibulla Bahar College, Dhaka, Bangladesh,  \n6 Department of Applied Chemistry and Chemical Engineering, University of Rajshahi, Rajshahi, Bangladesh, 7 Department of Microbiology, University of Dhaka, Dhaka, Bangladesh, 8 Department of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh, 9 Department of Pharmacy, BGC Trust University, Chattogram, Bangladesh  \n* [rsheikh1996@universepg.com](rsheikh1996@universepg.com)  \nAbstract  \nBackground  \nMesothelin (MSLN) is a cell surface glycoprotein that is often over-expressed in various malignancies of humans and has been suggested as a potential therapeutic and diagnostic target. However, its expression profile, clinical implications and drugtargeting potential are not fully understood and needs to be investigated across various cancer types.  \nObjectives  \nThe goal of this study was to systematically characterize the MSLN expression pattern, its prognostic value and functionality in different types of cancers, particularly in pancreatic adenocarcinoma (PAAD), as well as to identify viable therapeutic target opportunities.  \nMethods  \nTranscriptomic and clinical datasets from TCGA and GEO were used to evaluate the expression of the MSLN gene, diagnostic value, and its prognostic significance. To study the genomic alterations and functional pathways of MSLN, mutation, GO, and KEGG analyses were used. Drug sensitivity correlations were performed with GDSC and CTRP datasets. Structure-based drug discovery involved molecular docking (AutoDock Vina and Maestro Glide), 100 ns molecular dynamics simulations, and  \nPLOS One | [https://doi.org/10.1371/journal.pone.0354334](https://doi.org/10.1371/journal.pone.0354334) August 20, 2026 1 / 26  \n(OV), mesothelioma (MESO), and breast invasive carcinoma (BRCA) were obtained from The Cancer Genome Atlas (TCGA; TCGA-PAAD, TCGA-CHOL, TCGA-STAD, TCGA-LUAD, TCGAOV, TCGA-MESO, and TCGA-BRCA) . Microarray datasets GSE62452 and GSE15471 were retrieved from the Gene Expression Omnibus (GEO) database. The protein structure used for the molecular docking analysis was obtained from the RCSB Protein Data Bank (PDB; 7U9J) . All datasets analyzed during this study are publicly available from their ","cbCaifNFPTrD37xf","https://ap.wps.com/l/cbCaifNFPTrD37xf","pdf",2755405,26,"English","# Abstract\n## Background\n## Objectives\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What is the main goal of this study on mesothelin (MSLN)?\",\"answer\":\"To systematically characterize MSLN expression patterns, its prognostic value, and its functional/therapeutic targeting potential across cancers, with emphasis on pancreatic adenocarcinoma.\"},{\"question\":\"How were MSLN expression and diagnostic/prognostic effects evaluated?\",\"answer\":\"The study used transcriptomic and clinical datasets from TCGA and GEO to assess MSLN expression, diagnostic value (ROC analysis), and prognostic significance (survival and Cox regression).\"},{\"question\":\"Which computational approaches were used to explore therapeutic targeting?\",\"answer\":\"Genomic alterations and pathways were analyzed using mutation and functional enrichment (GO/KEGG). Drug sensitivity associations were tested with GDSC/CTRP, and structure-based screening used molecular docking plus 100 ns molecular dynamics and binding energy analysis, followed by ADMET-related assessments.\"}]","Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma - Research article | PDF",1790084311,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/083074537140c7a8505564a697ec3681.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e6a0bea78cd4e1eb707f18689da1c00.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/611d423650421ec5c18b9b4aefb1fb4e.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf10df6af812b9a5a75997824a1aabb4.webp",980,1268]